Skip to content
Search

Latest Stories

'Generally supportive' ACMD cautiously endorses emergency legislation to allow pharmacists to supply controlled drugs, but warns of 'misuse'

The Advisory Council on the Misuse of Drugs (ACMD) has cautiously endorsed the Home Office proposals to allow pharmacists to supply some controlled drugs without a prescription during the COVID-19 crisis.

In a letter on Tuesday (April 7), the ACMD wrote to Home Secretary Priti Patel that on balance the advisory council was “generally supportive" emergency legislative measure which would enable registered pharmacies to supply controlled drugs without a prescription during a pandemic.


However, it added that pharmacists would "require additional support and guidance, as they will be working outside of the scope of their usual practice in exceptional circumstances.”

The drug advisor also said that there "remains a risk that this measure could apply longer than is necessary" despite being brought in a pandemic for a limited time period.

Additionally, they said "whilst it will be necessary for the government to publicly announce in an emergency that these measures are to apply, common knowledge of the applicability of this measure may increase the risk of the misuse and diversion of controlled drugs."

The Home Secretary had, on April 1, asked the ACMD to respond to a proposal for an emergency legislation to “help secure access to controlled drugs within the healthcare system in a pandemic."

https://www.pharmacy.biz/emergency-legislation-could-allow-pharmacists-to-supply-controlled-drugs-without-a-prescription/

Meanwhile, backing the proposal to allow pharmacist-supervised supply of some controlled drugs without a prescription, the Royal Pharmaceutical Society said on Wednesday (April 8) that it would come up with “guidance to the profession to provide clarity and maintain high standards of supply, once the necessary legislation is passed.”

RPS President Sandra Gidley added: “The proposals that have been put forward are for the supply of controlled drugs in exceptional circumstances. They are likely to be used on occasion to make supplies to patients who have been receiving certain controlled drugs as part of on-going treatment.

“Pharmacists would use their professional judgement in line with safeguarding rules before making any supply, as well as working with other healthcare professionals involved in the care of the patient.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less